Generics and biosimilars warrant separate strategies and approaches. The Centre needs to ensure tighter controls before approval and periodic quality checks to ensure every batch shows consistent quality
#HealthMatters #India #Shortcuts #Biosimilars #ConfusingAffordability #EfficacyBadIdea
https://www.news18.com/india/health-matters-india-shortcuts-making-biosimilars-confusing-affordability-efficacy-bad-idea-8351533.html